R. William Hipkin

3.7k total citations
47 papers, 3.0k citations indexed

About

R. William Hipkin is a scholar working on Oncology, Immunology and Molecular Biology. According to data from OpenAlex, R. William Hipkin has authored 47 papers receiving a total of 3.0k indexed citations (citations by other indexed papers that have themselves been cited), including 17 papers in Oncology, 12 papers in Immunology and 11 papers in Molecular Biology. Recurrent topics in R. William Hipkin's work include Chemokine receptors and signaling (14 papers), Cannabis and Cannabinoid Research (10 papers) and Neuroscience and Neuropharmacology Research (6 papers). R. William Hipkin is often cited by papers focused on Chemokine receptors and signaling (14 papers), Cannabis and Cannabinoid Research (10 papers) and Neuroscience and Neuropharmacology Research (6 papers). R. William Hipkin collaborates with scholars based in United States, United Kingdom and Switzerland. R. William Hipkin's co-authors include Waldemar Gonsiorek, Mario Ascoli, Agnes Schönbrunn, Jay S. Fine, Xuedong Fan, Daniel Lundell, Charles A. Lunn, Satwant K. Narula, Richard B. Clark and Jesús Sánchez‐Yagüe and has published in prestigious journals such as Journal of Biological Chemistry, Journal of Clinical Oncology and The Journal of Clinical Endocrinology & Metabolism.

In The Last Decade

R. William Hipkin

47 papers receiving 2.9k citations

Peers

Countries citing papers authored by R. William Hipkin

Since Specialization

Citations

This map shows the geographic impact of R. William Hipkin's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by R. William Hipkin with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites R. William Hipkin more than expected).

Fields of papers citing papers by R. William Hipkin

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by R. William Hipkin. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by R. William Hipkin. The network helps show where R. William Hipkin may publish in the future.

Co-authorship network of co-authors of R. William Hipkin

This figure shows the co-authorship network connecting the top 25 collaborators of R. William Hipkin. A scholar is included among the top collaborators of R. William Hipkin based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with R. William Hipkin. R. William Hipkin is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	First-Line Nivolumab and Relatlimab Plus Chemotherapy for Gastric or Gastroesophageal Junction Adenocarcinoma: The Phase II RELATIVITY-060 Study 2024 ·Journal of Clinical Oncology ·(unknown), Guillermo Méndez, Joseph Chao, Radim Němeček, Kynan Feeney, Eric Van Cutsem, Salah‐Eddin Al‐Batran, Wasat Mansoor, N. Maisey, Roberto Pazo-Cid, Matthew Burge, David Pérez-Callejo, R. William Hipkin, (unknown), Ming Lei, Hao Tang, Satyendra Suryawanshi, Ronan J. Kelly, Niall C. Tebbutt	27
2	Expansion of SAR studies on triaryl bis sulfone cannabinoid CB2 receptor ligands 2010 ·Bioorganic & Medicinal Chemistry Letters ·Ling Tong, (unknown), Lei Chen, Razia Rizvi, Joseph Kelly, Eric J. Gilbert, Chunli Huang, Deyi Yang, Joseph A. Kozlowski, Neng‐Yang Shih, Waldemar Gonsiorek, R. William Hipkin, Asra Malikzay, Charles A. Lunn, Daniel Lundell	19
3	3,4-Diamino-1,2,5-thiadiazole as potent and selective CXCR2 antagonists 2009 ·Bioorganic & Medicinal Chemistry Letters ·(unknown), Arthur G. Taveras, Younong Yu, Junying Zheng, R. William Hipkin, James Fossetta, Xuedong Fan, Jay S. Fine, Daniel Lundell	8
4	Fluoroalkyl α side chain containing 3,4-diamino-cyclobutenediones as potent and orally bioavailable CXCR2–CXCR1 dual antagonists 2009 ·Bioorganic & Medicinal Chemistry Letters ·(unknown), Arthur G. Taveras, Michael P. Dwyer, Younong Yu, Jianhua Chao, R. William Hipkin, Xuedong Fan, Diane Rindgen, Jay S. Fine, Daniel Lundell	13
5	A Novel, Orally Active CXCR1/2 Receptor Antagonist, Sch527123, Inhibits Neutrophil Recruitment, Mucus Production, and Goblet Cell Hyperplasia in Animal Models of Pulmonary Inflammation 2007 ·Journal of Pharmacology and Experimental Therapeutics ·Richard W. Chapman, Michael Minnicozzi, Chander Celly, Jonathan E. Phillips, Ted T. Kung, R. William Hipkin, Xuedong Fan, Diane Rindgen, Gregory Deno, Richard Bond, Waldemar Gonsiorek, Motasim Billah, Jay S. Fine, John A. Hey	116
6	Biology and therapeutic potential of cannabinoid CB₂receptor inverse agonists 2007 ·British Journal of Pharmacology ·Charles A. Lunn, (unknown), Jay S. Fine, Brian J. Lavey, Joseph A. Kozlowski, R. William Hipkin, D J Lundell, (unknown)	101
7	3,4-Diamino-2,5-thiadiazole-1-oxides as potent CXCR2/CXCR1 antagonists 2007 ·Bioorganic & Medicinal Chemistry Letters ·(unknown), Arthur G. Taveras, Younong Yu, Junying Zheng, Jianhua Chao, Diane Rindgen, James Jakway, R. William Hipkin, James Fossetta, Xuedong Fan, Jay S. Fine, Hongchen Qiu, J. Robert Merritt, John J. Baldwin	16
8	Characterization of Peripheral Human Cannabinoid Receptor (hCB2) Expression and Pharmacology Using a Novel Radioligand, [35S]Sch225336 2006 ·Journal of Biological Chemistry ·Waldemar Gonsiorek, David Hesk, Shu‐Cheng Chen, David Kinsley, Jay S. Fine, James V. Jackson, Loretta A. Bober, Gregory Deno, Hong Bian, James Fossetta, Charles A. Lunn, Joseph A. Kozlowski, Brian J. Lavey, John J. Piwinski, Satwant K. Narula, Daniel Lundell, R. William Hipkin	20
9	A Novel Cannabinoid Peripheral Cannabinoid Receptor-Selective Inverse Agonist Blocks Leukocyte Recruitment in Vivo 2006 ·Journal of Pharmacology and Experimental Therapeutics ·Charles A. Lunn, Jay S. Fine, Alberto Rojas-Triana, James V. Jackson, Xuedong Fan, Ted T. Kung, Waldemar Gonsiorek, Martin A. Schwarz, Brian J. Lavey, Joseph A. Kozlowski, Satwant K. Narula, Daniel Lundell, R. William Hipkin, Loretta A. Bober	112
10	Murine CXCR1 Is a Functional Receptor for GCP-2/CXCL6 and Interleukin-8/CXCL8 2006 ·Journal of Biological Chemistry ·Xuedong Fan, Andriani C. Patera, (unknown), Gregory Deno, Waldemar Gonsiorek, Denise Manfra, Galya Vassileva, Ming Zeng, Craig E. Jackson, Lisa Sullivan, (unknown), Ghislain Opdenakker, Jo Van Damme, Joseph A. Hedrick, Daniel Lundell, Sérgio A. Lira, R. William Hipkin	171
11	Triaryl bis-sulfones as cannabinoid-2 receptor ligands: SAR studies 2005 ·Bioorganic & Medicinal Chemistry Letters ·Bandarpalle B. Shankar, Brian J. Lavey, Guowei Zhou, (unknown), Ling Tong, Razia Rizvi, Deyi Yang, Ronald Wolin, Joseph A. Kozlowski, Neng‐Yang Shih, Jie Wu, R. William Hipkin, Waldemar Gonsiorek, Charles A. Lunn	24
12	Pharmacological characterization of human S1P₄ using a novel radioligand, [4,5‐³H]‐dihydrosphingosine‐1‐phosphate 2004 ·British Journal of Pharmacology ·James Fossetta, Gregory Deno, Waldemar Gonsiorek, Xuedong Fan, Brian J. Lavey, Pradip R. Das, Charles A. Lunn, Paul J. Zavodny, Daniel Lundell, R. William Hipkin	9
13	Cloning and Pharmacological Characterization of CXCR1 and CXCR2 from Macaca fascicularis 2004 ·Journal of Pharmacology and Experimental Therapeutics ·R. William Hipkin, Gregory Deno, Jay S. Fine, Yongliang Sun, B. Wilburn, Xuedong Fan, Waldemar Gonsiorek, Maria Wiekowski	11
14	Evaluation of Signal Transduction Pathways in Chemoattractant-Induced Human Monocyte Chemotaxis 2001 ·Inflammation ·Jay S. Fine, (unknown), Paul J. Zavodny, R. William Hipkin	39
15	Protein Kinase C Activation Stimulates the Phosphorylation and Internalization of the sst2A Somatostatin Receptor 2000 ·Journal of Biological Chemistry ·R. William Hipkin, Yining Wang, Agnes Schönbrunn	72
16	Desensitization of β2-Adrenergic Receptors with Mutations of the Proposed G Protein-coupled Receptor Kinase Phosphorylation Sites 1998 ·Journal of Biological Chemistry ·(unknown), Bridgette January, Jacqueline Friedman, R. William Hipkin, Richard B. Clark	73
17	Immunohistochemical Localization of Somatostatin Receptors sst2A in Human Tumors 1998 ·American Journal Of Pathology ·Jean Claude Reubi, Андреас Каппелер, Beatrice Waser, Jean A. Laissue, R. William Hipkin, Agnes Schönbrunn	117
18	Agonist-induced Desensitization, Internalization, and Phosphorylation of the sst2A Somatostatin Receptor 1997 ·Journal of Biological Chemistry ·R. William Hipkin, Jacqueline Friedman, Richard B. Clark, C. Mark Eppler, Agnes Schönbrunn	144
19	Truncation of the C-terminal Tail of the Follitropin Receptor Does Not Impair the Agonist- or Phorbol Ester-induced Receptor Phosphorylation and Uncoupling 1995 ·Journal of Biological Chemistry ·R. William Hipkin, Xuebo Liu, Mario Ascoli	53
20	Interaction between cyclic nucleotide second messenger systems in murine Leydig cells 1991 ·Molecular and Cellular Endocrinology ·R. William Hipkin, William H. Moger	8

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact